These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10840182)

  • 1. Effects of cholinesterase inhibitors on a two-component chained schedule performance in rats.
    Liu WF
    Neurotoxicol Teratol; 2000; 22(3):389-96. PubMed ID: 10840182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antimuscarinic antiparkinsonian drugs on brightness discrimination performance in rats.
    Liu WF
    Pharmacol Biochem Behav; 1996 Jun; 54(2):425-30. PubMed ID: 8743605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.
    Cuadra G; Summers K; Giacobini E
    J Pharmacol Exp Ther; 1994 Jul; 270(1):277-84. PubMed ID: 7913496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat.
    De Sarno P; Pomponi M; Giacobini E; Tang XC; Williams E
    Neurochem Res; 1989 Oct; 14(10):971-7. PubMed ID: 2608162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats.
    Giarola A; Auber A; Chiamulera C
    Behav Pharmacol; 2011 Feb; 22(1):1-6. PubMed ID: 21116174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholinesterase inhibitors and clonidine coadministration on rat cortex neurotransmitters in vivo.
    Cuadra G; Giacobini E
    J Pharmacol Exp Ther; 1995 Oct; 275(1):228-36. PubMed ID: 7562554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-maze.
    Iijima S; Greig NH; Garofalo P; Spangler EL; Heller B; Brossi A; Ingram DK
    Neurosci Lett; 1992 Sep; 144(1-2):79-83. PubMed ID: 1436716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of various drugs including organophosphorus compounds (OPC) and therapeutic compounds against OPC on DRL responding.
    Bizot JC
    Pharmacol Biochem Behav; 1998 Apr; 59(4):1069-80. PubMed ID: 9586869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic response to tacrine (THA) and physostigmine in the aged rat brain.
    Bassant MH; Jazat-Poindessous F; Lamour Y
    J Cereb Blood Flow Metab; 1995 Nov; 15(6):1093-102. PubMed ID: 7593342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats.
    Xiao WB; Nordberg A; Zhang X
    J Pharmacol Exp Ther; 1993 May; 265(2):759-64. PubMed ID: 8496822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinolytic antagonism to the disruptive effects of oral low doses of pyridostigmine on simple discrimination performance in rats.
    Liu WF
    Pharmacol Biochem Behav; 1991 Dec; 40(4):745-9. PubMed ID: 1816561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
    Easwaramoorthy B; Pichika R; Collins D; Potkin SG; Leslie FM; Mukherjee J
    Synapse; 2007 Jan; 61(1):29-36. PubMed ID: 17068780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics.
    Greig NH; De Micheli E; Holloway HW; Yu QS; Utsuki T; Perry TA; Brossi A; Ingram DK; Deutsch J; Lahiri DK; Soncrant TT
    Acta Neurol Scand Suppl; 2000; 176():74-84. PubMed ID: 11261809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cholinergic drugs on neocortical EEG and flash-visual evoked potentials in the mouse.
    Tebano MT; Luzi M; Palazzesi S; Pomponi M; Loizzo A
    Neuropsychobiology; 1999; 40(1):47-56. PubMed ID: 10420101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the subchronic treatment with the acetylcholinesterase inhibitor heptastigmine on central cholinergic transmission and memory impairment in aged rats.
    Garrone B; Luparini MR; Tolu L; Magnani M; Landolfi C; Milanese C
    Neurosci Lett; 1998 Mar; 245(1):53-7. PubMed ID: 9596354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor dysfunction produced by tacrine administration in rats.
    Carriero DL; Outslay G; Mayorga AJ; Aberman J; Gianutsos G; Salamone JD
    Pharmacol Biochem Behav; 1997 Dec; 58(4):851-8. PubMed ID: 9408186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.
    Galli A; Mori F
    Arch Toxicol; 1991; 65(4):330-4. PubMed ID: 1953352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects of physostigmine as a pretreatment in guinea pigs.
    Philippens IH; Wolthuis OL; Busker RW; Langenberg JP; Melchers BP
    Pharmacol Biochem Behav; 1996 Sep; 55(1):99-105. PubMed ID: 8870044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cholinesterase inhibitors on learning and memory in rats: a brief review with special reference to THA.
    Mohammed AH
    Acta Neurol Scand Suppl; 1993; 149():13-5. PubMed ID: 8128832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of oral pyridostigmine bromide on conditioned operant performance in rats.
    Shih JH; Liu WF; Lee SF; Lee JD; Ma C; Lin CH
    Pharmacol Biochem Behav; 1991 Mar; 38(3):549-53. PubMed ID: 2068191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.